{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["ADCC", "BEAST", "IgA/IgG ratio", "V1V2 antibody binding", "epidemiologically-linked infection", "human immunodeficiency virus (HIV)", "protective immune parameters and host factors", "viral signature K169"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31139189", "DateCompleted": {"Year": "2020", "Month": "08", "Day": "13"}, "DateRevised": {"Year": "2020", "Month": "08", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "05", "Day": "14"}], "Language": ["eng"], "ELocationID": ["1062", "10.3389/fimmu.2019.01062"], "Journal": {"ISSN": "1664-3224", "JournalIssue": {"Volume": "10", "PubDate": {"Year": "2019"}}, "Title": "Frontiers in immunology", "ISOAbbreviation": "Front Immunol"}, "ArticleTitle": "Immune Correlates of Disease Progression in Linked HIV-1 Infection.", "Pagination": {"StartPage": "1062", "MedlinePgn": "1062"}, "Abstract": {"AbstractText": ["Genetic and immunologic analyses of epidemiologically-linked HIV transmission enable insights into the impact of immune responses on clinical outcomes. Human vaccine trials and animal studies of HIV-1 infection have suggested immune correlates of protection; however, their role in natural infection in terms of protection from disease progression is mostly unknown. Four HIV-1<sup>+</sup> Cameroonian individuals, three of them epidemiologically-linked in a polygamous heterosexual relationship and one incidence-matched case, were studied over 15 years for heterologous and cross-neutralizing antibody responses, antibody binding, IgA/IgG levels, antibody-dependent cellular cytotoxicity (ADCC) against cells expressing wild-type or CD4-bound Env, viral evolution, Env epitopes, and host factors including HLA-I alleles. Despite viral infection with related strains, the members of the transmission cluster experienced contrasting clinical outcomes including cases of rapid progression and long-term non-progression in the absence of strongly protective HLA-I or CCR5\u039432 alleles. Slower progression and higher CD4/CD8 ratios were associated with enhanced IgG antibody binding to native Env and stronger V1V2 antibody binding responses in the presence of viruses with residue K169 in V2. ADCC against cells expressing Env in the CD4-bound conformation in combination with low Env-specific IgA/IgG ratios correlated with better clinical outcome. This data set highlights for the first time that V1V2-directed antibody responses and ADCC against cells expressing open, CD4-exposed Env, in the presence of low plasma IgA/IgG ratios, can correlate with clinical outcome in natural infection. These parameters are comparable to the major correlates of protection, identified <i>post-hoc</i> in the RV144 vaccine trial; thus, they may also modulate the rate of clinical progression once infected. The findings illustrate the potential of immune correlate analysis in natural infection to guide vaccine development."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathology, New York University School of Medicine, New York, NY, United States."}], "LastName": "Tuen", "ForeName": "Michael", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathology, New York University School of Medicine, New York, NY, United States."}, {"Identifier": [], "Affiliation": "Department of Biochemistry, University of Yaound\u00e9 1, Yaound\u00e9, Cameroon."}], "LastName": "Bimela", "ForeName": "Jude S", "Initials": "JS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathology, New York University School of Medicine, New York, NY, United States."}, {"Identifier": [], "Affiliation": "Faculty of Medicine and Biomedical Sciences, University of Yaound\u00e9 1, Yaound\u00e9, Cameroon."}], "LastName": "Banin", "ForeName": "Andrew N", "Initials": "AN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre de Recherche du CHUM, Montr\u00e9al, QC, Canada."}, {"Identifier": [], "Affiliation": "D\u00e9partement de Microbiologie, Infectiologie et Immunologie, Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, QC, Canada."}], "LastName": "Ding", "ForeName": "Shilei", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "South African MRC Bioinformatics Unit, South African National Bioinformatics Institute, University of the Western Cape, Bellville, South Africa."}], "LastName": "Harkins", "ForeName": "Gordon W", "Initials": "GW"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States."}], "LastName": "Weiss", "ForeName": "Svenja", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States."}], "LastName": "Itri", "ForeName": "Vincenza", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Intramural Research, National Institutes of Health-National Institute of Allergy and Infectious Diseases, Bethesda, MD, United States."}], "LastName": "Durham", "ForeName": "Allison R", "Initials": "AR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Genomics Unit, Research Technologies Branch, Division of Intramural Research, Rocky Mountain Laboratories, NIAID, NIH, Hamilton, MT, United States."}], "LastName": "Porcella", "ForeName": "Stephen F", "Initials": "SF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathology, New York University School of Medicine, New York, NY, United States."}], "LastName": "Soni", "ForeName": "Sonal", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathology, New York University School of Medicine, New York, NY, United States."}], "LastName": "Mayr", "ForeName": "Luzia", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Diagnostic Center, Yaound\u00e9, Cameroon."}, {"Identifier": [], "Affiliation": "Yaound\u00e9 General Hospital, Yaound\u00e9, Cameroon."}], "LastName": "Meli", "ForeName": "Josephine", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Medicine and Biomedical Sciences, University of Yaound\u00e9 1, Yaound\u00e9, Cameroon."}, {"Identifier": [], "Affiliation": "\"Chantal Biya\" International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaound\u00e9, Cameroon."}], "LastName": "Torimiro", "ForeName": "Judith N", "Initials": "JN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center of Research for Emerging and Re-Emerging Diseases, Institute of Medical Research and Study of Medicinal Plants, Yaound\u00e9, Cameroon."}, {"Identifier": [], "Affiliation": "School of Laboratory Medicine and Medical Sciences, Nelson R. Mandela School of Medicine, KwaZulu-Natal Research Innovation and Sequencing Platform, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa."}], "LastName": "Tongo", "ForeName": "Marcel", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Veterans Affairs New York Harbor Healthcare Systems, New York, NY, United States."}], "LastName": "Wang", "ForeName": "Xiaohong", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY, United States."}], "LastName": "Kong", "ForeName": "Xiang-Peng", "Initials": "XP"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "New York University School of Medicine, Institute of Environmental Medicine, New York, NY, United States."}], "LastName": "N\u00e1das", "ForeName": "Arthur", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre de Recherche du CHUM, Montr\u00e9al, QC, Canada."}, {"Identifier": [], "Affiliation": "Department of Medicine, Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, QC, Canada."}, {"Identifier": [], "Affiliation": "Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, La Jolla, CA, United States."}], "LastName": "Kaufmann", "ForeName": "Daniel E", "Initials": "DE"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada."}, {"Identifier": [], "Affiliation": "British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Vancouver, BC, Canada."}], "LastName": "Brumme", "ForeName": "Zabrina L", "Initials": "ZL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathology, New York University School of Medicine, New York, NY, United States."}, {"Identifier": [], "Affiliation": "Medical Diagnostic Center, Yaound\u00e9, Cameroon."}, {"Identifier": [], "Affiliation": "\"Chantal Biya\" International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaound\u00e9, Cameroon."}], "LastName": "Nanfack", "ForeName": "Aubin J", "Initials": "AJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Intramural Research, National Institutes of Health-National Institute of Allergy and Infectious Diseases, Bethesda, MD, United States."}, {"Identifier": [], "Affiliation": "Department of Medicine, Johns Hopkins University, Baltimore, MD, United States."}], "LastName": "Quinn", "ForeName": "Thomas C", "Initials": "TC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States."}], "LastName": "Zolla-Pazner", "ForeName": "Susan", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Intramural Research, National Institutes of Health-National Institute of Allergy and Infectious Diseases, Bethesda, MD, United States."}, {"Identifier": [], "Affiliation": "Department of Medicine, Johns Hopkins University, Baltimore, MD, United States."}], "LastName": "Redd", "ForeName": "Andrew D", "Initials": "AD"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre de Recherche du CHUM, Montr\u00e9al, QC, Canada."}, {"Identifier": [], "Affiliation": "D\u00e9partement de Microbiologie, Infectiologie et Immunologie, Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, QC, Canada."}, {"Identifier": [], "Affiliation": "Department of Microbiology and Immunology, McGill University, Montr\u00e9al, QC, Canada."}], "LastName": "Finzi", "ForeName": "Andr\u00e9s", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathology, New York University School of Medicine, New York, NY, United States."}], "LastName": "Gorny", "ForeName": "Miroslaw K", "Initials": "MK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathology, New York University School of Medicine, New York, NY, United States."}, {"Identifier": [], "Affiliation": "Veterans Affairs New York Harbor Healthcare Systems, New York, NY, United States."}], "LastName": "Nyambi", "ForeName": "Phillipe N", "Initials": "PN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathology, New York University School of Medicine, New York, NY, United States."}], "LastName": "Duerr", "ForeName": "Ralf", "Initials": "R"}], "GrantList": [{"GrantID": "D43 TW009604", "Acronym": "TW", "Agency": "FIC NIH HHS", "Country": "United States"}, {"GrantID": "R01 AI083142", "Acronym": "AI", "Agency": "NIAID NIH HHS", "Country": "United States"}, {"GrantID": "R56 AI083142", "Acronym": "AI", "Agency": "NIAID NIH HHS", "Country": "United States"}, {"GrantID": "UM1 AI126617", "Acronym": "AI", "Agency": "NIAID NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Immunol", "NlmUniqueID": "101560960", "ISSNLinking": "1664-3224"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antibodies, Neutralizing"}, {"RegistryNumber": "0", "NameOfSubstance": "HIV Antibodies"}, {"RegistryNumber": "0", "NameOfSubstance": "Immunoglobulin A"}, {"RegistryNumber": "0", "NameOfSubstance": "Immunoglobulin G"}, {"RegistryNumber": "0", "NameOfSubstance": "env Gene Products, Human Immunodeficiency Virus"}], "MeshHeadingList": [{"QualifierName": ["immunology"], "DescriptorName": "Antibodies, Neutralizing"}, {"QualifierName": [], "DescriptorName": "Antibody-Dependent Cell Cytotoxicity"}, {"QualifierName": [], "DescriptorName": "CD4-CD8 Ratio"}, {"QualifierName": [], "DescriptorName": "Disease Progression"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["blood"], "DescriptorName": "HIV Antibodies"}, {"QualifierName": ["immunology", "transmission"], "DescriptorName": "HIV Infections"}, {"QualifierName": ["immunology"], "DescriptorName": "HIV-1"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["blood"], "DescriptorName": "Immunoglobulin A"}, {"QualifierName": ["blood"], "DescriptorName": "Immunoglobulin G"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["immunology"], "DescriptorName": "env Gene Products, Human Immunodeficiency Virus"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Gautam R, Nishimura Y, Pegu A, Nason MC, Klein F, Gazumyan A, et al. . A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges. Nature. (2016) 533:105\u20139. 10.1038/nature17677", "ArticleIdList": ["10.1038/nature17677", "PMC5127204", "27120156"]}, {"Citation": "Hessell AJ, Jaworski JP, Epson E, Matsuda K, Pandey S, Kahl C, et al. . Early short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in infant macaques. Nat Med. (2016) 22:362\u20138. 10.1038/nm.4063", "ArticleIdList": ["10.1038/nm.4063", "PMC4983100", "26998834"]}, {"Citation": "Zolla-Pazner S. A critical question for HIV vaccine development: which antibodies to induce? Science. (2014) 345:167\u20138. 10.1126/science.1256526", "ArticleIdList": ["10.1126/science.1256526", "PMC4481191", "25013066"]}, {"Citation": "Haynes BF, Gilbert PB, McElrath MJ, Zolla-Pazner S, Tomaras GD, Alam SM, et al. . Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N Engl J Med. (2012) 366:1275\u201386. 10.1056/NEJMoa1113425", "ArticleIdList": ["10.1056/NEJMoa1113425", "PMC3371689", "22475592"]}, {"Citation": "Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, et al. . Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med. (2009) 361:2209\u201320. 10.1056/NEJMoa0908492", "ArticleIdList": ["10.1056/NEJMoa0908492", "19843557"]}, {"Citation": "Zolla-Pazner S, deCamp A, Gilbert PB, Williams C, Yates NL, Williams WT, et al. . Vaccine-induced IgG antibodies to V1V2 regions of multiple HIV-1 subtypes correlate with decreased risk of HIV-1 infection. PLoS ONE. (2014) 9:e87572. 10.1371/journal.pone.0087572", "ArticleIdList": ["10.1371/journal.pone.0087572", "PMC3913641", "24504509"]}, {"Citation": "Rolland M, Edlefsen PT, Larsen BB, Tovanabutra S, Sanders-Buell E, Hertz T, et al. . Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2. Nature. (2012) 490:417\u201320. 10.1038/nature11519", "ArticleIdList": ["10.1038/nature11519", "PMC3551291", "22960785"]}, {"Citation": "Tomaras GD, Ferrari G, Shen X, Alam SM, Liao HX, Pollara J, et al. . Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG. Proc Natl Acad Sci USA. (2013) 110:9019\u201324. 10.1073/pnas.1301456110", "ArticleIdList": ["10.1073/pnas.1301456110", "PMC3670311", "23661056"]}, {"Citation": "Barouch DH, Tomaka FL, Wegmann F, Stieh DJ, Alter G, Robb ML, et al. Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial. (APPROACH) and in rhesus monkeys. (NHP 13\u201319). Lancet. (2018) 18:31364\u20133 10.1016/S0140-6736(18)31364-3", "ArticleIdList": ["10.1016/S0140-6736(18)31364-3", "PMC6192527", "30047376"]}, {"Citation": "Gordon SN, Liyanage NP, Doster MN, Vaccari M, Vargas-Inchaustegui DA, Pegu P, et al. . Boosting of ALVAC-SIV vaccine-primed macaques with the CD4-SIVgp120 fusion protein elicits antibodies to V2 associated with a decreased risk of SIVmac251 acquisition. J Immunol. (2016) 197:2726\u201337. 10.4049/jimmunol.1600674", "ArticleIdList": ["10.4049/jimmunol.1600674", "PMC5026031", "27591322"]}, {"Citation": "Boesch AW, Osei-Owusu NY, Crowley AR, Chu TH, Chan YN, Weiner JA, et al. . Biophysical and Functional Characterization of Rhesus Macaque IgG Subclasses. Front Immunol. (2016) 7:589. 10.3389/fimmu.2016.00589", "ArticleIdList": ["10.3389/fimmu.2016.00589", "PMC5153528", "28018355"]}, {"Citation": "Rogers KA, Jayashankar L, Scinicariello F, Attanasio R. Nonhuman primate IgA: genetic heterogeneity and interactions with CD89. J Immunol. (2008) 180:4816\u201324. 10.4049/jimmunol.180.7.4816", "ArticleIdList": ["10.4049/jimmunol.180.7.4816", "18354205"]}, {"Citation": "Tomaras GD, Plotkin SA. Complex immune correlates of protection in HIV-1 vaccine efficacy trials. Immunol Rev. (2017) 275:245\u201361. 10.1111/imr.12514", "ArticleIdList": ["10.1111/imr.12514", "PMC5330182", "28133811"]}, {"Citation": "Martin MP, Carrington M. Immunogenetics of HIV disease. Immunol Rev. (2013) 254:245\u201364. 10.1111/imr.12071", "ArticleIdList": ["10.1111/imr.12071", "PMC3703621", "23772624"]}, {"Citation": "Ackerman ME, Mikhailova A, Brown EP, Dowell KG, Walker BD, Bailey-Kellogg C, et al. . Polyfunctional HIV-specific antibody responses are associated with spontaneous HIV control. PLoS Pathog. (2016) 12:e1005315. 10.1371/journal.ppat.1005315", "ArticleIdList": ["10.1371/journal.ppat.1005315", "PMC4706315", "26745376"]}, {"Citation": "Bournazos S, Klein F, Pietzsch J, Seaman MS, Nussenzweig MC, Ravetch JV. Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in vivo activity. Cell. (2014) 158:1243\u201353. 10.1016/j.cell.2014.08.023", "ArticleIdList": ["10.1016/j.cell.2014.08.023", "PMC4167398", "25215485"]}, {"Citation": "Hessell AJ, Hangartner L, Hunter M, Havenith CE, Beurskens FJ, Bakker JM, et al. Fc receptor but not complement binding is important in antibody protection against HIV. Nature. (2007) 449:101\u20134. 10.1038/nature06106", "ArticleIdList": ["10.1038/nature06106", "17805298"]}, {"Citation": "Veillette M, Desormeaux A, Medjahed H, Gharsallah NE, Coutu M, Baalwa J, et al. . Interaction with cellular CD4 exposes HIV-1 envelope epitopes targeted by antibody-dependent cell-mediated cytotoxicity. J Virol. (2014) 88:2633\u201344. 10.1128/JVI.03230-13", "ArticleIdList": ["10.1128/JVI.03230-13", "PMC3958102", "24352444"]}, {"Citation": "Neil SJ, Zang T, Bieniasz PD. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature. (2008) 451:425\u201330. 10.1038/nature06553", "ArticleIdList": ["10.1038/nature06553", "18200009"]}, {"Citation": "Arias JF, Heyer LN, von Bredow B, Weisgrau KL, Moldt B, Burton DR, et al. . Tetherin antagonism by Vpu protects HIV-infected cells from antibody-dependent cell-mediated cytotoxicity. Proc Natl Acad Sci USA. (2014) 111:6425\u201330. 10.1073/pnas.1321507111", "ArticleIdList": ["10.1073/pnas.1321507111", "PMC4035966", "24733916"]}, {"Citation": "Alsahafi N, Ding S, Richard J, Markle T, Brassard N, Walker B, et al. . Nef Proteins from HIV-1 elite controllers are inefficient at preventing antibody-dependent cellular cytotoxicity. J Virol. (2015) 90:2993\u20133002. 10.1128/JVI.02973-15", "ArticleIdList": ["10.1128/JVI.02973-15", "PMC4810628", "26719277"]}, {"Citation": "Alsahafi N, Richard J, Prevost J, Coutu M, Brassard N, Parsons MS, et al. . Impaired downregulation of NKG2D ligands by nef proteins from elite controllers sensitizes HIV-1-infected cells to antibody-dependent cellular cytotoxicity. J Virol. (2017) 91:e00109\u201317. 10.1128/JVI.00109-17", "ArticleIdList": ["10.1128/JVI.00109-17", "PMC5533916", "28615199"]}, {"Citation": "Veillette M, Coutu M, Richard J, Batraville LA, Dagher O, Bernard N, et al. . The HIV-1 gp120 CD4-bound conformation is preferentially targeted by antibody-dependent cellular cytotoxicity-mediating antibodies in sera from HIV-1-infected individuals. J Virol. (2015) 89:545\u201351. 10.1128/JVI.02868-14", "ArticleIdList": ["10.1128/JVI.02868-14", "PMC4301108", "25339767"]}, {"Citation": "Liao HX, Bonsignori M, Alam SM, McLellan JS, Tomaras GD, Moody MA, et al. . Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2. Immunity. (2013) 38:176\u201386. 10.1016/j.immuni.2012.11.011", "ArticleIdList": ["10.1016/j.immuni.2012.11.011", "PMC3569735", "23313589"]}, {"Citation": "Streeck H, Jessen H, Kuecherer C, Li B, Jessen AB, Dupke S, et al. . Epidemiologically linked transmission of HIV-1 illustrates the impact of host genetics on virological outcome. AIDS. (2009) 23:259\u201362. 10.1097/QAD.0b013e328315a78b", "ArticleIdList": ["10.1097/QAD.0b013e328315a78b", "PMC3082841", "19098497"]}, {"Citation": "Ssemwanga D, Doria-Rose NA, Redd AD, Shiakolas AR, Longosz AF, Nsubuga RN, et al. . Characterization of the neutralizing antibody response in a case of genetically linked HIV superinfection. J Infect Dis. (2018) 217:1530\u201334. 10.1093/infdis/jiy071", "ArticleIdList": ["10.1093/infdis/jiy071", "PMC6065500", "29579256"]}, {"Citation": "Beretta M, Moreau A, Bouvin-Pley M, Essat A, Goujard C, Chaix ML, et al. . Phenotypic properties of envelope glycoproteins of transmitted HIV-1 variants from patients belonging to transmission chains. AIDS. (2018) 32:1917\u201326. 10.1097/QAD.0000000000001906", "ArticleIdList": ["10.1097/QAD.0000000000001906", "29927786"]}, {"Citation": "Kouyos RD, Rusert P, Kadelka C, Huber M, Marzel A, Ebner H, et al. . Tracing HIV-1 strains that imprint broadly neutralizing antibody responses. Nature. (2018). 10.1038/s41586-018-0517-0", "ArticleIdList": ["10.1038/s41586-018-0517-0", "30202088"]}, {"Citation": "Scarlatti G. Mother-to-child transmission of HIV-1: advances and controversies of the twentieth centuries. AIDS Rev. (2004) 6:67\u201378.", "ArticleIdList": ["15332429"]}, {"Citation": "Kumar A, Smith CEP, Giorgi EE, Eudailey J, Martinez DR, Yusim K, et al. . Infant transmitted/founder HIV-1 viruses from peripartum transmission are neutralization resistant to paired maternal plasma. PLoS Pathog. (2018) 14:e1006944. 10.1371/journal.ppat.1006944", "ArticleIdList": ["10.1371/journal.ppat.1006944", "PMC5908066", "29672607"]}, {"Citation": "Moore PL, Gray ES, Sheward D, Madiga M, Ranchobe N, Lai Z, et al. . Potent and broad neutralization of HIV-1 subtype C by plasma antibodies targeting a quaternary epitope including residues in the V2 loop. J Virol. (2011) 85:3128\u201341. 10.1128/JVI.02658-10", "ArticleIdList": ["10.1128/JVI.02658-10", "PMC3067856", "21270156"]}, {"Citation": "Forthal DN, Finzi A. Antibody-dependent cellular cytotoxicity in HIV infection. AIDS. (2018) 32:2439\u201351. 10.1097/QAD.0000000000002011", "ArticleIdList": ["10.1097/QAD.0000000000002011", "PMC6497078", "30234611"]}, {"Citation": "Richard J, Prevost J, Alsahafi N, Ding S, Finzi A. Impact of HIV-1 Envelope Conformation on ADCC Responses. Trends Microbiol. (2018) 26:253\u201365. 10.1016/j.tim.2017.10.007", "ArticleIdList": ["10.1016/j.tim.2017.10.007", "29162391"]}, {"Citation": "Pollara J, Bonsignori M, Moody MA, Pazgier M, Haynes BF, Ferrari G. Epitope specificity of human immunodeficiency virus-1 antibody dependent cellular cytotoxicity [ADCC] responses. Curr HIV Res. (2013) 11:378\u201387 10.2174/1570162X113116660059", "ArticleIdList": ["10.2174/1570162X113116660059", "PMC3878369", "24191939"]}, {"Citation": "von Bredow B, Arias JF, Heyer LN, Moldt B, Le K, Robinson JE, et al. . Comparison of antibody-dependent cell-mediated cytotoxicity and virus neutralization by HIV-1 Env-specific monoclonal antibodies. J Virol. (2016) 90:6127\u201339. 10.1128/JVI.00347-16", "ArticleIdList": ["10.1128/JVI.00347-16", "PMC4907221", "27122574"]}, {"Citation": "Anand SP, Grover JR, Tolbert WD, Prevost J, Richard J, Ding S, et al. . Antibody-induced internalization of HIV-1 Env proteins limits the surface expression of the closed conformation of Env. J Virol. (2019). 10.1128/JVI.00293-19. [Epub ahead of print].", "ArticleIdList": ["10.1128/JVI.00293-19", "PMC6532100", "30894474"]}, {"Citation": "Richard J, Prevost J, Baxter AE, von Bredow B, Ding S, Medjahed H, et al. . Uninfected bystander cells impact the measurement of HIV-specific antibody-dependent cellular cytotoxicity responses. MBio. (2018) 9:e00358\u201318. 10.1128/mBio.00358-18", "ArticleIdList": ["10.1128/mBio.00358-18", "PMC5874913", "29559570"]}, {"Citation": "Prevost J, Zoubchenok D, Richard J, Veillette M, Pacheco B, Coutu M, et al. . Influence of the envelope gp120 Phe 43 cavity on HIV-1 sensitivity to antibody-dependent cell-mediated cytotoxicity responses. J Virol. (2017) 91:e02452\u201316. 10.1128/JVI.02452-16", "ArticleIdList": ["10.1128/JVI.02452-16", "PMC5355605", "28100618"]}, {"Citation": "Alsahafi N, Bakouche N, Kazemi M, Richard J, Ding S, Bhattacharyya S, et al. . An asymmetric opening of HIV-1 envelope mediates antibody-dependent cellular cytotoxicity. Cell Host Microbe. (2019) 25:578\u201387 e5. 10.1016/j.chom.2019.03.002", "ArticleIdList": ["10.1016/j.chom.2019.03.002", "PMC6592637", "30974085"]}, {"Citation": "Vaccari M, Fourati S, Gordon SN, Brown DR, Bissa M, Schifanella L, et al. . HIV vaccine candidate activation of hypoxia and the inflammasome in CD14(+) monocytes is associated with a decreased risk of SIVmac251 acquisition. Nat Med. (2018) 24:847\u201356. 10.1038/s41591-018-0025-7", "ArticleIdList": ["10.1038/s41591-018-0025-7", "PMC5992093", "29785023"]}, {"Citation": "Horwitz JA, Bar-On Y, Lu CL, Fera D, Lockhart AAK, Lorenzi JCC, et al. . Non-neutralizing antibodies alter the course of HIV-1 infection in vivo. Cell. (2017) 170:637\u201348 e10. 10.1016/j.cell.2017.06.048", "ArticleIdList": ["10.1016/j.cell.2017.06.048", "PMC5554461", "28757252"]}, {"Citation": "Gurdasani D, Iles L, Dillon DG, Young EH, Olson AD, Naranbhai V, et al. . A systematic review of definitions of extreme phenotypes of HIV control and progression. AIDS. (2014) 28:149\u201362. 10.1097/QAD.0000000000000049", "ArticleIdList": ["10.1097/QAD.0000000000000049", "PMC3882304", "24149086"]}, {"Citation": "Powell RL, Urbanski MM, Burda S, Kinge T, Nyambi PN. High frequency of HIV-1 dual infections among HIV-positive individuals in Cameroon, West Central Africa. J Acquir Immune Defic Syndr. (2009) 50:84\u201392. 10.1097/QAI.0b013e31818d5a40", "ArticleIdList": ["10.1097/QAI.0b013e31818d5a40", "19295338"]}, {"Citation": "Lu W, Mehraj V, Vyboh K, Cao W, Li T, Routy JP. CD4:CD8 ratio as a frontier marker for clinical outcome, immune dysfunction and viral reservoir size in virologically suppressed HIV-positive patients. J Int AIDS Soc. (2015) 18:20052. 10.7448/IAS.18.1.20052", "ArticleIdList": ["10.7448/IAS.18.1.20052", "PMC4486418", "26130226"]}, {"Citation": "Konikoff J, Brookmeyer R, Longosz AF, Cousins MM, Celum C, Buchbinder SP, et al. . Performance of a limiting-antigen avidity enzyme immunoassay for cross-sectional estimation of HIV incidence in the United States. PLoS ONE. (2013) 8:e82772. 10.1371/journal.pone.0082772", "ArticleIdList": ["10.1371/journal.pone.0082772", "PMC3873916", "24386116"]}, {"Citation": "Courtney CR, Mayr L, Nanfack AJ, Banin AN, Tuen M, Pan R, et al. . Contrasting antibody responses to intrasubtype superinfection with CRF02_AG. PLoS ONE. (2017) 12:e0173705. 10.1371/journal.pone.0173705", "ArticleIdList": ["10.1371/journal.pone.0173705", "PMC5348025", "28288209"]}, {"Citation": "Salazar-Gonzalez JF, Bailes E, Pham KT, Salazar MG, Guffey MB, Keele BF, et al. . Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing. J Virol. (2008) 82:3952\u201370. 10.1128/JVI.02660-07", "ArticleIdList": ["10.1128/JVI.02660-07", "PMC2293010", "18256145"]}, {"Citation": "Nanfack AJ, Redd AD, Bimela JS, Ncham G, Achem E, Banin AN, et al. . Multimethod Longitudinal HIV Drug Resistance Analysis in Antiretroviral-Therapy-Naive Patients. J Clin Microbiol. (2017) 55:2785\u2013800. 10.1128/JCM.00634-17", "ArticleIdList": ["10.1128/JCM.00634-17", "PMC5648714", "28659324"]}, {"Citation": "Rambaut A.\nFigTree. Molecular Evolution, Phylogenetics and Epidemiology. 1.4 edn.\nEdinburgh, UK: University of Edinburgh, Institute of Evolutionary Biology;  (2012). Available online at: http://tree.bio.ed.ac.uk/software/figtree"}, {"Citation": "Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol. (2011) 28:2731\u20139. 10.1093/molbev/msr121", "ArticleIdList": ["10.1093/molbev/msr121", "PMC3203626", "21546353"]}, {"Citation": "Robertson DL, Hahn BH, Sharp PM. Recombination in AIDS viruses. J Mol Evol. (1995) 40:249\u201359 10.1007/BF00163230", "ArticleIdList": ["10.1007/BF00163230", "7723052"]}, {"Citation": "Drummond AJ, Suchard MA, Xie D, Rambaut A. Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mol Biol Evol. (2012) 29:1969\u201373. 10.1093/molbev/mss075", "ArticleIdList": ["10.1093/molbev/mss075", "PMC3408070", "22367748"]}, {"Citation": "Lemey P, Rambaut A, Drummond AJ, Suchard MA. Bayesian phylogeography finds its roots. PLoS Comput Biol. (2009) 5:e1000520. 10.1371/journal.pcbi.1000520", "ArticleIdList": ["10.1371/journal.pcbi.1000520", "PMC2740835", "19779555"]}, {"Citation": "Lemey P, Rambaut A, Welch JJ, Suchard MA. Phylogeography takes a relaxed random walk in continuous space and time. Mol Biol Evol. (2010) 27:1877\u201385. 10.1093/molbev/msq067", "ArticleIdList": ["10.1093/molbev/msq067", "PMC2915639", "20203288"]}, {"Citation": "Ayres DL, Darling A, Zwickl DJ, Beerli P, Holder MT, Lewis PO, et al. . BEAGLE: an application programming interface and high-performance computing library for statistical phylogenetics. Syst Biol. (2012) 61:170\u20133. 10.1093/sysbio/syr100", "ArticleIdList": ["10.1093/sysbio/syr100", "PMC3243739", "21963610"]}, {"Citation": "Suchard MA, Weiss RE, Sinsheimer JS. Bayesian selection of continuous-time Markov chain evolutionary models. Mol Biol Evol. (2001) 18:1001\u201313. 10.1093/oxfordjournals.molbev.a003872", "ArticleIdList": ["10.1093/oxfordjournals.molbev.a003872", "11371589"]}, {"Citation": "Drummond AJ, Ho SY, Phillips MJ, Rambaut A. Relaxed phylogenetics and dating with confidence. PLoS Biol. (2006) 4:e88. 10.1371/journal.pbio.0040088", "ArticleIdList": ["10.1371/journal.pbio.0040088", "PMC1395354", "16683862"]}, {"Citation": "Gill MS, Lemey P, Faria NR, Rambaut A, Shapiro B, Suchard MA. Improving Bayesian population dynamics inference: a coalescent-based model for multiple loci. Mol Biol Evol. (2013) 30:713\u201324. 10.1093/molbev/mss265", "ArticleIdList": ["10.1093/molbev/mss265", "PMC3563973", "23180580"]}, {"Citation": "Tavar\u00e9 S. Some probabilistic and statistical problems in the analysis of DNA sequences. Lect Math Life Sci. (1986) 17:57\u201386"}, {"Citation": "Yang Z. Maximum likelihood phylogenetic estimation from DNA sequences with variable rates over sites: approximate methods. J Mol Evol. (1994) 39:306\u201314 10.1007/BF00160154", "ArticleIdList": ["10.1007/BF00160154", "7932792"]}, {"Citation": "Novitsky V, Wang R, Rossenkhan R, Moyo S, Essex M. Intra-host evolutionary rates in HIV-1C env and gag during primary infection. Infect Genet Evol. (2013) 19:361\u20138. 10.1016/j.meegid.2013.02.023", "ArticleIdList": ["10.1016/j.meegid.2013.02.023", "PMC3759599", "23523818"]}, {"Citation": "Kass RE, Raftery AE. Bayes Factors. J Am Stat Assoc. (2012) 90:773\u201395. 10.1080/01621459.1995.10476572", "ArticleIdList": ["10.1080/01621459.1995.10476572"]}, {"Citation": "Minin VN, Suchard MA. Counting labeled transitions in continuous-time Markov models of evolution. J Math Biol. (2008) 56:391\u2013412. 10.1007/s00285-007-0120-8", "ArticleIdList": ["10.1007/s00285-007-0120-8", "17874105"]}, {"Citation": "Minin VN, Suchard MA. Fast, accurate and simulation-free stochastic mapping. Philos Trans R Soc Lond B Biol Sci. (2008) 363:3985\u201395. 10.1098/rstb.2008.0176", "ArticleIdList": ["10.1098/rstb.2008.0176", "PMC2607419", "18852111"]}, {"Citation": "Bielejec F, Baele G, Vrancken B, Suchard MA, Rambaut A, Lemey P. SpreaD3: interactive visualization of spatiotemporal history and trait evolutionary processes. Mol Biol Evol. (2016) 33:2167\u20139. 10.1093/molbev/msw082", "ArticleIdList": ["10.1093/molbev/msw082", "PMC6398721", "27189542"]}, {"Citation": "Brockman MA, Brumme ZL, Brumme CJ, Miura T, Sela J, Rosato PC, et al. . Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated for in chronic infection. J Virol. (2010) 84:11937\u201349. 10.1128/JVI.01086-10", "ArticleIdList": ["10.1128/JVI.01086-10", "PMC2977869", "20810731"]}, {"Citation": "Mwimanzi P, Markle TJ, Martin E, Ogata Y, Kuang XT, Tokunaga M, et al. . Attenuation of multiple Nef functions in HIV-1 elite controllers. Retrovirology. (2013) 10:1. 10.1186/1742-4690-10-1", "ArticleIdList": ["10.1186/1742-4690-10-1", "PMC3564836", "23289738"]}, {"Citation": "Alexander L, Weiskopf E, Greenough TC, Gaddis NC, Auerbach MR, Malim MH, et al. . Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection. J Virol. (2000) 74:4361\u201376 10.1128/JVI.74.9.4361-4376.2000", "ArticleIdList": ["10.1128/JVI.74.9.4361-4376.2000", "PMC111953", "10756051"]}, {"Citation": "Klein F, Nogueira L, Nishimura Y, Phad G, West AP, Jr, Halper-Stromberg A, et al. . Enhanced HIV-1 immunotherapy by commonly arising antibodies that target virus escape variants. J Exp Med. (2014) 211:2361\u201372. 10.1084/jem.20141050", "ArticleIdList": ["10.1084/jem.20141050", "PMC4235636", "25385756"]}, {"Citation": "Li M, Gao F, Mascola JR, Stamatatos L, Polonis VR, Koutsoukos M, et al. . Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. J Virol. (2005) 79:10108\u201325. 10.1128/JVI.79.16.10108-10125.2005", "ArticleIdList": ["10.1128/JVI.79.16.10108-10125.2005", "PMC1182643", "16051804"]}, {"Citation": "Cortez V, Odem-Davis K, McClelland RS, Jaoko W, Overbaugh J. HIV-1 superinfection in women broadens and strengthens the neutralizing antibody response. PLoS Pathog. (2012) 8:e1002611. 10.1371/journal.ppat.1002611", "ArticleIdList": ["10.1371/journal.ppat.1002611", "PMC3315492", "22479183"]}, {"Citation": "Zolla-Pazner S, Kong XP, Jiang X, Cardozo T, Nadas A, Cohen S, et al. . Cross-clade HIV-1 neutralizing antibodies induced with V3-scaffold protein immunogens following priming with gp120 DNA. J Virol. (2011) 85:9887\u201398. 10.1128/JVI.05086-11", "ArticleIdList": ["10.1128/JVI.05086-11", "PMC3196418", "21795338"]}, {"Citation": "Prevost J, Richard J, Ding S, Pacheco B, Charlebois R, Hahn BH, et al. . Envelope glycoproteins sampling states 2/3 are susceptible to ADCC by sera from HIV-1-infected individuals. Virology. (2018) 515:38\u201345. 10.1016/j.virol.2017.12.002", "ArticleIdList": ["10.1016/j.virol.2017.12.002", "PMC5843759", "29248757"]}, {"Citation": "Veillette M, Coutu M, Richard J, Batraville LA, Desormeaux A, Roger M, et al. . Conformational evaluation of HIV-1 trimeric envelope glycoproteins using a cell-based ELISA assay. J Vis Exp. (2014) 51995. 10.3791/51995", "ArticleIdList": ["10.3791/51995", "PMC4828074", "25286159"]}, {"Citation": "Bonsignori M, Pollara J, Moody MA, Alpert MD, Chen X, Hwang KK, et al. . Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family. J Virol. (2012) 86:11521\u201332. 10.1128/JVI.01023-12", "ArticleIdList": ["10.1128/JVI.01023-12", "PMC3486290", "22896626"]}, {"Citation": "Jiang X, Totrov M, Li W, Sampson JM, Williams C, Lu H, et al. . Rationally Designed Immunogens targeting HIV-1 gp120 V1V2 induce distinct conformation-specific antibody responses in rabbits. J Virol. (2016) 90:11007\u201319. 10.1128/JVI.01409-16", "ArticleIdList": ["10.1128/JVI.01409-16", "PMC5126360", "27707920"]}, {"Citation": "Liu L, Li L, Nanfack A, Mayr LM, Soni S, Kohutnicki A, et al. . Anti-V2 antibody deficiency in individuals infected with HIV-1 in Cameroon. Virology. (2019) 529:57\u201364. 10.1016/j.virol.2019.01.011", "ArticleIdList": ["10.1016/j.virol.2019.01.011", "PMC6512328", "30665098"]}, {"Citation": "McLellan JS, Pancera M, Carrico C, Gorman J, Julien JP, Khayat R, et al. . Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9. Nature. (2011) 480:336\u201343. 10.1038/nature10696", "ArticleIdList": ["10.1038/nature10696", "PMC3406929", "22113616"]}, {"Citation": "Pan R, Gorny MK, Zolla-Pazner S, Kong XP. The V1V2 Region of HIV-1 gp120 Forms a five-stranded beta barrel. J Virol. (2015) 89:8003\u201310. 10.1128/JVI.00754-15", "ArticleIdList": ["10.1128/JVI.00754-15", "PMC4505664", "26018158"]}, {"Citation": "Zolla-Pazner S, Edlefsen PT, Rolland M, Kong XP, deCamp A, Gottardo R, et al. . Vaccine-induced human antibodies specific for the third variable region of HIV-1 gp120 impose immune pressure on infecting viruses. EBioMed. (2014) 1:37\u201345. 10.1016/j.ebiom.2014.10.022", "ArticleIdList": ["10.1016/j.ebiom.2014.10.022", "PMC4293639", "25599085"]}, {"Citation": "Huang CC, Tang M, Zhang MY, Majeed S, Montabana E, Stanfield RL, et al. . Structure of a V3-containing HIV-1 gp120 core. Science. (2005) 310:1025\u20138. 10.1126/science.1118398", "ArticleIdList": ["10.1126/science.1118398", "PMC2408531", "16284180"]}, {"Citation": "Georgiev IS, Joyce MG, Yang Y, Sastry M, Zhang B, Baxa U, et al. . Single-Chain Soluble BG505.SOSIP gp140 trimers as structural and antigenic mimics of mature closed HIV-1 Env. J Virol. (2015) 89:5318\u201329. 10.1128/JVI.03451-14", "ArticleIdList": ["10.1128/JVI.03451-14", "PMC4442528", "25740988"]}, {"Citation": "Arnold P, Himmels P, Weiss S, Decker TM, Markl J, Gatterdam V, et al. . Antigenic and 3D structural characterization of soluble X4 and hybrid X4-R5 HIV-1 Env trimers. Retrovirology. (2014) 11:42. 10.1186/1742-4690-11-42", "ArticleIdList": ["10.1186/1742-4690-11-42", "PMC4048260", "24884925"]}, {"Citation": "Cotton LA, Abdur Rahman M, Ng C, Le AQ, Milloy MJ, Mo T, et al. . HLA class I sequence-based typing using DNA recovered from frozen plasma. J Immunol Methods. (2012) 382:40\u20137. 10.1016/j.jim.2012.05.003", "ArticleIdList": ["10.1016/j.jim.2012.05.003", "22584155"]}, {"Citation": "Goulder PJ, Walker BD. HIV and HLA class I: an evolving relationship. Immunity. (2012) 37:426\u201340. 10.1016/j.immuni.2012.09.005", "ArticleIdList": ["10.1016/j.immuni.2012.09.005", "PMC3966573", "22999948"]}, {"Citation": "O'Brien SJ, Hendrickson SL. Host genomic influences on HIV/AIDS. Genome Biol. (2013) 14:201. 10.1186/gb-2013-14-1-201", "ArticleIdList": ["10.1186/gb-2013-14-1-201", "PMC3663097", "23369251"]}, {"Citation": "Tang J, Wilson CM, Meleth S, Myracle A, Lobashevsky E, Mulligan MJ, et al. . Host genetic profiles predict virological and immunological control of HIV-1 infection in adolescents. AIDS. (2002) 16:2275\u201384 10.1097/00002030-200211220-00007", "ArticleIdList": ["10.1097/00002030-200211220-00007", "12441799"]}, {"Citation": "R_Core_Team. R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing;  Available onlline at: http://www.R-project.org/ (2014)."}]}], "History": [{"Year": "2019", "Month": "2", "Day": "21"}, {"Year": "2019", "Month": "4", "Day": "25"}, {"Year": "2019", "Month": "5", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "5", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "8", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "1", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["31139189", "PMC6527802", "10.3389/fimmu.2019.01062"]}}]}